SMI
11.891,36
PKT
-35,75
PKT
-0,30
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
12.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
12.04.22 | Givaudan Underweight | Barclays Capital | |
12.04.22 | Givaudan Add | Baader Bank | |
12.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
12.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
12.04.22 | Givaudan Underperform | Jefferies & Company Inc. | |
11.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
11.04.22 | Richemont Outperform | RBC Capital Markets | |
11.04.22 | Richemont Buy | Jefferies & Company Inc. | |
08.04.22 | Novartis Neutral | UBS AG | |
07.04.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
07.04.22 | Swiss Re Sell | UBS AG | |
07.04.22 | Swiss Re Hold | Jefferies & Company Inc. | |
07.04.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
06.04.22 | Nestlé Buy | UBS AG | |
06.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
06.04.22 | Nestlé Overweight | Barclays Capital | |
05.04.22 | UBS Outperform | RBC Capital Markets | |
05.04.22 | UBS Sector Perform | RBC Capital Markets | |
05.04.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
05.04.22 | Novartis Sell | Deutsche Bank AG | |
05.04.22 | Richemont Overweight | JP Morgan Chase & Co. | |
04.04.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
04.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
04.04.22 | Richemont Buy | UBS AG | |
04.04.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
04.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
01.04.22 | UBS Overweight | JP Morgan Chase & Co. | |
01.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
01.04.22 | UBS Outperform | Credit Suisse Group | |
31.03.22 | Roche Buy | Deutsche Bank AG | |
31.03.22 | UBS Neutral | Goldman Sachs Group Inc. | |
31.03.22 | UBS Buy | Goldman Sachs Group Inc. | |
30.03.22 | Nestlé Neutral | Credit Suisse Group | |
30.03.22 | Roche Overweight | Barclays Capital | |
30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.